Get startedLog in
    Picture of Sichuan Kelun-Biotech Biopharmaceutical logo

    6990 — Sichuan Kelun-Biotech Biopharmaceutical News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapHigh Flyer
    All News

    Brief: Kelun-Biotech's Novel ADC Drug SKB518 Has Been Granted The Clearance Of IND From The United States Food And Drug Administration (FDA)

    Picture of Sichuan Kelun-Biotech Biopharmaceutical logoSichuan Kelun-Biotech Biopharmaceutical
    21/04/2025 13:02
    April 21 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd 6990.HK:

KELUN-BIOTECH'S NOVEL ADC DRUG SKB518 HAS BEEN GRANTED THE CLEARANCE OF IND FROM THE UNITED STATES FOOD AND DRUG ADMINISTRATION (FDA)

Source text: ID:nPn1V9Rjwa

Further company coverage: 6990.HK

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Sichuan Kelun-Biotech Biopharmaceutical

    See all news